Danaher Corporation (DHR) fundamentals: P/E, valuation, undervalued?
Danaher Corporation · Health Care · ref. ETF XLV · price $222.84
In short — Danaher Corporation trades at 39.7× earnings (P/E), 24.0× forward, with a net margin of 15.9 % and revenue growth of +6 %. Read: Cheap for the growth (P/E 24 for ~60% growth (PEG 0.4)).
Is Danaher Corporation stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$222.84+8.1% over range
Oct 14, 25low $161.91 · high $242.05Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
77% recommend buying · 13 analysts
Valuation : Cheap for the growth — P/E 24 for ~60% growth (PEG 0.4)
Valuation
39.7
P/E (price/earnings)
24.0
Forward P/E
0.67
PEG
3.0
Price/book (P/B)
$156.7B
Market cap
5.61
EPS
Profitability & growth
15.9 %
Net margin
+6 %
Revenue growth
+60 %
Earnings growth
$27.9B
Total debt
Danaher Corporation income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $31.5B | $7.1B | 22.6 % |
| 2023 | $23.9B | $4.7B | 19.9 % |
| 2024 | $23.9B | $3.9B | 16.3 % |
| 2025 | $24.6B | $3.6B | 14.7 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Danaher Corporation's P/E and is the stock undervalued? What's a good P/E?
Danaher Corporation's P/E is 39.7 (forward 24.0). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Danaher Corporation profitable?
Danaher Corporation has a net margin of 15.9 % (EPS 5.61). The company is profitable.
Is DHR stock expensive?
Our read: "Cheap for the growth" — P/E 24 for ~60% growth (PEG 0.4). Cross-check with growth and sector.
💬 A question about Danaher Corporation? The JPI assistant answers using our backtest data.
Keep exploring Danaher Corporation